0001845022-22-000085 | 10-Q | XBRL Viewer

Print Document View Excel Document

Cover - shares	6 Months Ended
Cover - shares	Jul. 31, 2022	Aug. 31, 2022
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jul. 31, 2022
Document Transition Report	false
Entity File Number	001-40601
Entity Registrant Name	Couchbase, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	26-3576987
Entity Address, Street	3250 Olcott Street
Entity Address, City	Santa Clara
Entity Address, State	CA
Entity Address, Postal Zip Code	95054
City Area Code	650
Local Phone Number	417-7500
Title of each class	Common stock, par value $0.00001 per share
Trading Symbol(s)	BASE
Name of each exchange on which registered	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		44,786,337
Entity Central Index Key	0001845022
Current Fiscal Year End Date	--01-31
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q2
Amendment Flag	false

CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) - USD ($) $ in Thousands	Jul. 31, 2022	Jan. 31, 2022
Current assets
Cash and cash equivalents	$ 46,338	$ 95,688
Short-term investments	145,767	110,266
Accounts receivable, net	29,018	36,696
Deferred commissions	11,525	11,783
Prepaid expenses and other current assets	9,655	8,559
Total current assets	242,303	262,992
Property and equipment, net	5,639	4,288
Operating lease right-of-use assets	7,696	0
Deferred commissions, noncurrent	7,798	8,243
Other assets	1,334	1,219
Total assets	264,770	276,742
Current liabilities
Accounts payable	5,579	1,923
Accrued compensation and benefits	10,530	16,143
Other accrued expenses	4,103	3,231
Operating lease liabilities	3,075	0
Deferred revenue	67,139	69,010
Total current liabilities	90,426	90,307
Operating lease liabilities, noncurrent	5,491	0
Deferred revenue, noncurrent	2,467	2,713
Other liabilities	0	507
Total liabilities	98,384	93,527
Commitments and contingencies (Note 9)
Stockholders’ equity
Preferred stock, $0.00001 par value; 200,000,000 shares authorized as of July 31, 2022 and January 31, 2022; zero shares issued outstanding as of July 31, 2022 and January 31, 2022	0	0
Common stock, $0.00001 par value; 1,000,000,000 shares authorized as of July 31, 2022 and January 31, 2022; 44,771,717 and 43,847,484 shares issued and outstanding as of July 31, 2022 and January 31, 2022, respectively	0	0
Additional paid-in capital	544,614	525,392
Accumulated other comprehensive loss	(1,043)	(195)
Accumulated deficit	(377,185)	(341,982)
Total stockholders’ equity	166,386	183,215
Total liabilities and stockholders’ equity	$ 264,770	$ 276,742

CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) (Parenthetical) - $ / shares	Jul. 31, 2022	Jan. 31, 2022
Statement of Financial Position [Abstract]
Preferred stock, par value (in dollars per share)	$ 0.00001	$ 0.00001
Preferred stock, shares authorized (in shares)	200,000,000	200,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.00001	$ 0.00001
Common stock, shares authorized (in shares)	1,000,000,000	1,000,000,000
Common stock, shares issued (in shares)	44,771,717	43,847,484
Common stock, shares outstanding (in shares)	44,771,717	43,847,484

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021
Revenue:
Total revenue	$ 39,791	$ 29,699	$ 74,644	$ 57,654
Cost of revenue:
Total cost of revenue	4,781	3,525	9,432	6,917
Gross profit	35,010	26,174	65,212	50,737
Operating expenses:
Research and development	14,341	12,623	28,762	25,164
Sales and marketing	27,473	22,263	54,316	42,897
General and administrative	8,429	5,278	16,355	10,775
Total operating expenses	50,243	40,164	99,433	78,836
Loss from operations	(15,233)	(13,990)	(34,221)	(28,099)
Interest expense	(25)	(252)	(50)	(497)
Other income (expense), net	261	(77)	(295)	7
Loss before income taxes	(14,997)	(14,319)	(34,566)	(28,589)
Provision for income taxes	372	151	637	480
Net loss	(15,369)	(14,470)	(35,203)	(29,069)
Cumulative dividends on Series G redeemable convertible preferred stock	0	(1,438)	0	(2,917)
Net loss attributable to common stockholders	(15,369)	(15,908)	(35,203)	(31,986)
Net loss attributable to common stockholders	$ (15,369)	$ (15,908)	$ (35,203)	$ (31,986)
Net loss per share attributable to common stockholders, basic (in dollars per share)	$ (0.34)	$ (1.76)	$ (0.79)	$ (4.16)
Net loss per share attributable to common stockholders, diluted (in dollars per share)	$ (0.34)	$ (1.76)	$ (0.79)	$ (4.16)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares)	44,648	9,045	44,459	7,696
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in shares)	44,648	9,045	44,459	7,696
Subscription
Revenue:
Total revenue	$ 37,059	$ 28,029	$ 69,040	$ 54,494
Cost of revenue:
Total cost of revenue	2,521	2,072	4,917	4,124
Services
Revenue:
Total revenue	2,732	1,670	5,604	3,160
Cost of revenue:
Total cost of revenue	2,260	1,453	4,515	2,793
License \| Subscription
Revenue:
Total revenue	6,382	4,416	11,389	8,694
Support and other \| Subscription
Revenue:
Total revenue	$ 30,677	$ 23,613	$ 57,651	$ 45,800

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021
Statement of Comprehensive Income [Abstract]
Net loss	$ (15,369)	$ (14,470)	$ (35,203)	$ (29,069)
Other comprehensive income (loss):
Net unrealized gains (losses) on investments, net of tax	(162)	1	(848)	(1)
Total comprehensive loss	$ (15,531)	$ (14,469)	$ (36,051)	$ (29,070)

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 65
-Paragraph 1
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 50
-Paragraph 6
-URI https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 8
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580

Reference 25: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 7
-URI https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 32: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 33: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 34: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599

Reference 35: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

+ Details

CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) (unaudited) - USD ($) $ in Thousands	Total	Redeemable Convertible Preferred Stock	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning balance at Jan. 31, 2021		$ 259,822
Beginning balance (in shares) at Jan. 31, 2021		26,070,213
Increase (Decrease) in Temporary Equity
Conversion of redeemable convertible preferred stock to common stock upon initial public offering		$ (259,822)
Conversion of redeemable convertible preferred stock to common stock upon initial public offering (in shares)		(26,070,213)
Ending balance at Jul. 31, 2021		$ 0
Ending balance (in shares) at Jul. 31, 2021		0
Beginning balance at Jan. 31, 2021	$ (246,342)		$ 0	$ 37,410	$ 1	$ (283,753)
Beginning balance (in shares) at Jan. 31, 2021			6,199,305
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options	4,288			4,288
Issuance of common stock upon exercise of stock options (in shares)			783,052
Conversion of redeemable convertible preferred stock to common stock upon initial public offering	259,822			259,822
Conversion of redeemable convertible preferred stock to common stock upon initial public offering (in shares)			26,710,600
Issuance of common stock in connection with initial public offering, net of underwriting discounts and commissions and other issuance costs	209,924			209,924
Issuance of common stock in connection with initial public offering, net of underwriting discounts and commissions and other issuance costs (in shares)			9,589,999
Settlement of fractional shares to be paid in cash	(9)			(9)
Settlement of fractional shares to be paid in cash (in shares)			(15)
Stock-based compensation	3,810			3,810
Net unrealized gains (losses) on investments	(1)				(1)
Net loss	(29,069)					(29,069)
Ending balance at Jul. 31, 2021	202,423		$ 0	515,245	0	(312,822)
Ending balance (in shares) at Jul. 31, 2021			43,282,941
Beginning balance at Apr. 30, 2021		$ 259,822
Beginning balance (in shares) at Apr. 30, 2021		26,070,213
Increase (Decrease) in Temporary Equity
Conversion of redeemable convertible preferred stock to common stock upon initial public offering		$ (259,822)
Conversion of redeemable convertible preferred stock to common stock upon initial public offering (in shares)		(26,070,213)
Ending balance at Jul. 31, 2021		$ 0
Ending balance (in shares) at Jul. 31, 2021		0
Beginning balance at Apr. 30, 2021	(257,667)		$ 0	40,686	(1)	(298,352)
Beginning balance (in shares) at Apr. 30, 2021			6,460,868
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options	2,841			2,841
Issuance of common stock upon exercise of stock options (in shares)			521,489
Conversion of redeemable convertible preferred stock to common stock upon initial public offering	259,822			259,822
Conversion of redeemable convertible preferred stock to common stock upon initial public offering (in shares)			26,710,600
Issuance of common stock in connection with initial public offering, net of underwriting discounts and commissions and other issuance costs	209,924			209,924
Issuance of common stock in connection with initial public offering, net of underwriting discounts and commissions and other issuance costs (in shares)			9,589,999
Settlement of fractional shares to be paid in cash	(9)			(9)
Settlement of fractional shares to be paid in cash (in shares)			(15)
Stock-based compensation	1,981			1,981
Net unrealized gains (losses) on investments	1				1
Net loss	(14,470)					(14,470)
Ending balance at Jul. 31, 2021	202,423		$ 0	515,245	0	(312,822)
Ending balance (in shares) at Jul. 31, 2021			43,282,941
Beginning balance at Jan. 31, 2022		$ 0
Beginning balance (in shares) at Jan. 31, 2022		0
Ending balance at Jul. 31, 2022		$ 0
Ending balance (in shares) at Jul. 31, 2022		0
Beginning balance at Jan. 31, 2022	$ 183,215		$ 0	525,392	(195)	(341,982)
Beginning balance (in shares) at Jan. 31, 2022	43,847,484		43,847,484
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options	$ 3,367			3,367
Issuance of common stock upon exercise of stock options (in shares)			560,931
Issuance of common stock in connection with employee stock purchase plan	3,525			3,525
Issuance of common stock in connection with employee stock purchase plan (in shares)			237,499
Vesting of restricted stock units (in shares)			125,803
Stock-based compensation	12,330			12,330
Net unrealized gains (losses) on investments	(848)				(848)
Net loss	(35,203)					(35,203)
Ending balance at Jul. 31, 2022	$ 166,386		$ 0	544,614	(1,043)	(377,185)
Ending balance (in shares) at Jul. 31, 2022	44,771,717		44,771,717
Beginning balance at Apr. 30, 2022		$ 0
Beginning balance (in shares) at Apr. 30, 2022		0
Ending balance at Jul. 31, 2022		$ 0
Ending balance (in shares) at Jul. 31, 2022		0
Beginning balance at Apr. 30, 2022	$ 174,284		$ 0	536,981	(881)	(361,816)
Beginning balance (in shares) at Apr. 30, 2022			44,537,296
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options	753
Issuance of common stock upon exercise of stock options (in shares)			108,618
Vesting of restricted stock units (in shares)			125,803
Stock-based compensation	6,880			6,880
Net unrealized gains (losses) on investments	(162)				(162)
Net loss	(15,369)					(15,369)
Ending balance at Jul. 31, 2022	$ 166,386		$ 0	$ 544,614	$ (1,043)	$ (377,185)
Ending balance (in shares) at Jul. 31, 2022	44,771,717		44,771,717

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021
Cash flows from operating activities
Net loss	$ (35,203)	$ (29,069)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation and amortization	1,466	1,406
Amortization of debt issuance costs	0	15
Stock-based compensation, net of amounts capitalized	12,177	3,810
Amortization of deferred commissions	8,410	6,326
Non-cash lease expense	1,400	0
Foreign currency transaction losses	1,036	5
Other	301	68
Changes in operating assets and liabilities
Accounts receivable	7,329	15,845
Deferred commissions	(7,706)	(7,071)
Prepaid expenses and other assets	(1,214)	(5,848)
Accounts payable	3,543	4,553
Accrued compensation and benefits	(5,608)	(91)
Accrued expenses and other liabilities	1,035	(1,749)
Operating lease liabilities	(1,111)	0
Deferred revenue	(2,117)	(7,375)
Net cash used in operating activities	(16,262)	(19,175)
Cash flows from investing activities
Purchases of short-term investments	(69,468)	(7,133)
Maturities of short-term investments	32,802	12,285
Additions to property and equipment	(2,476)	(250)
Net cash provided by (used in) investing activities	(39,142)	4,902
Cash flows from financing activities
Proceeds from exercise of stock options	3,367	4,288
Proceeds from issuance of common stock under ESPP	3,525	0
Proceeds from initial public offering, net of underwriting discounts and commissions	0	214,854
Payments of deferred offering costs	0	(2,795)
Net cash provided by financing activities	6,892	216,347
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(838)	(125)
Net increase (decrease) in cash, cash equivalents and restricted cash	(49,350)	201,949
Cash, cash equivalents and restricted cash
Beginning of period	96,231	37,840
End of period	46,881	239,789
Cash and cash equivalents	46,338	239,246
Restricted cash included in other assets	543	543
Supplemental disclosures of cash activities
Cash paid for income taxes	359	442
Cash paid for interest	50	495
Non-cash investing and financing activities:
Stock-based compensation capitalized as internal-use software costs	153	0
Net change in unrealized gains or losses on available-for-sale debt securities	(848)	(1)
Change in deferred offering costs included in accounts payable and other accrued expenses	0	1,051
Change in purchases of property and equipment included in accounts payable and other accrued expenses	194	230
Conversion of redeemable convertible preferred stock to common stock	$ 0	$ 259,822

Description of Business	6 Months Ended
Description of Business	Jul. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Description of Business	Description of BusinessCouchbase, Inc. provides an enterprise-class, multi-cloud NoSQL database architected on top of an open source foundation. Couchbase was incorporated in the State of Delaware in 2008 and is headquartered in Santa Clara, California. In these notes to the unaudited condensed consolidated financial statements, the “Company,” “Couchbase,” “we,” “us” and “our” refers to Couchbase, Inc. and its subsidiaries on a consolidated basis.

Basis of Presentation and Summary of Significant Accounting Policies	6 Months Ended
	Jul. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation and Summary of Significant Accounting Policies	Basis of Presentation and Summary of Significant Accounting Policies Basis of Presentation The Company’s unaudited condensed consolidated financial statements and accompanying notes have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”), regarding interim financial reporting. As permitted under those rules, certain footnotes or other financial information that are normally required by GAAP have been condensed or omitted, and accordingly the balance sheet as of January 31, 2022, and related disclosures, have been derived from the audited consolidated financial statements at that date but do not include all the information required by GAAP for complete consolidated financial statements. These unaudited condensed consolidated financial statements have been prepared on the same basis as the Company’s annual consolidated financial statements and, in the opinion of management, reflect all adjustments (consisting of only normal recurring adjustments) that are necessary for the fair statement of the Company’s condensed consolidated financial information. The results of operations for the three and six months ended July 31, 2022, are not necessarily indicative of the results to be expected for the year ending January 31, 2023, or for any other interim period or for any other future year. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and the related notes contained in the Company’s Annual Report on Form 10-K for the year ended January 31, 2022, as filed with the SEC on March 31, 2022. Initial Public Offering In July 2021, the Company completed its initial public offering (“IPO”), for the sale and issuance of 9,589,999 shares of its common stock at $24.00 per share, which included 1,250,869 shares issued pursuant to the exercise of the underwriters’ option to purchase additional shares. The Company received net proceeds of $214.9 million, after deducting underwriters’ discounts and commissions and before consideration of other issuance costs. In connection with the IPO, all 26,710,600 shares of outstanding redeemable convertible preferred stock automatically converted into an equivalent number of shares of common stock, inclusive of 640,387 shares of additional stock issued related to preferred stock conversion and dividend features. Reverse Stock Split On June 30, 2021, the Company effected a 2.5-for-1 reverse stock split of its outstanding common stock, common stock warrants, preferred stock, and stock option awards. All issued and outstanding shares of common stock, common stock warrants, preferred stock, stock option awards and per share data have been adjusted in these condensed consolidated financial statements, on a retrospective basis, to reflect the reverse stock split for all periods presented. The par value of the common stock and preferred stock was not adjusted because of the reverse stock split. Fiscal Year The Company’s fiscal year ends on January 31. Unless otherwise stated, references to year in these condensed consolidated financial statements relate to fiscal year rather than calendar year. Principles of Consolidation The accompanying condensed consolidated financial statements include the accounts of Couchbase, Inc. and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. Use of Estimates The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts stated in the financial statements and accompanying notes. Such estimates include standalone selling prices for each distinct performance obligation, capitalized internal-use software costs, expected period of benefit for deferred commissions, valuation of the Company’s common stock prior to the IPO in July 2021, valuation of stock-based awards, the determination of allowance for doubtful accounts, the incremental borrowing rate used to measure operating liabilities, and accounting for income taxes. The Company bases its estimates on historical experience and assumptions that management considers reasonable. The Company assesses these estimates on a regular basis; however, actual results could differ from these estimates. Estimates and assumptions about future events and their effects, including the impact of the COVID-19 pandemic, cannot be determined with certainty and therefore require increased judgment. These estimates and assumptions may change in future periods and will be recognized in the condensed consolidated financial statements as new events occur and additional information becomes known. To the extent the Company’s actual results differ materially from those estimates and assumptions, the Company’s future financial statements could be affected. COVID-19 While the duration and extent of the COVID-19 pandemic depends on future developments that cannot be accurately predicted at this time, such as the extent and effectiveness of containment actions, it has already had an adverse effect on the global economy and the lasting effects of the pandemic continue to be unknown. The Company may experience customer losses, including due to bankruptcy or customers ceasing operations, which may result in delays in collections or an inability to collect accounts receivable from these customers. The impact of COVID-19 on the Company’s financial condition, results of operations, or liquidity continues to remain uncertain, and as of the date of issuance of these financial statements, the Company is not aware of any specific event or circumstance that would require an update to its estimates or judgments or an adjustment to the carrying value of the Company’s assets or liabilities. These estimates may change, as new events occur and additional information is obtained, which will be recognized in the condensed consolidated financial statements as soon as they become known. Actual results could differ from those estimates, and any such differences may be material to the Company’s financial statements. Significant Accounting Policies Except for the accounting policy for leases, which was updated as a result of adopting a new accounting standard, there have been no material changes to the significant accounting policies that were disclosed in the Company’s Annual Report on Form 10-K for the fiscal year ended January 31, 2022. See “Recently Adopted Accounting Pronouncements” below for additional information on the impact of the adoption of the new accounting standard for leases on the Company’s consolidated financial statements. Recent Accounting Pronouncements Recently Adopted Accounting Pronouncements In August 2018, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2018-15, Intangibles—Goodwill and Other— Internal-Use Software, which aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal use software license). The accounting for the service element of a hosting arrangement that is a service contract is not affected by the amendments in this ASU. The Company adopted this guidance on February 1, 2022 prospectively for implementation costs incurred after the date of adoption, and the adoption did not have a material impact on its consolidated financial statements. In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which simplifies the accounting for income taxes by amending and clarifying existing guidance in ASC 740, as well as removing certain exceptions within ASC 740. The Company adopted this guidance on February 1, 2022, and the adoption did not have a material impact on its consolidated financial statements. Leases In February 2016, the FASB issued Accounting Standards Update (“ASU”) No. 2016-02 and several amendments, codified as ASC 842, Leases which amends the existing accounting standards for leases. The new standard requires lessees to record a right-of-use (“ROU”) asset and a corresponding lease liability on the balance sheet (with the exception of short-term leases). For lessees, leases will continue to be classified as either operating or financing in the income statement. The Company adopted the guidance on February 1, 2022 utilizing the modified retrospective transition method through a cumulative-effect adjustment at the beginning of the first quarter of fiscal 2023. The Company elected the package of transitional practical expedients upon which, among other provisions, allowed the Company not to reassess under the new standard prior conclusions about lease identification, lease classification and initial direct costs, for any existing leases on the adoption date. The Company elected not to record leases that, at the commencement date, have a lease term of 12 months or less. The Company did not elect to apply the hindsight practical expedient when determining lease term and assessing impairment of ROU assets. The Company also did not elect to combine its lease and non-lease components. Non-lease components that are not fixed are expensed as incurred as variable lease payments. Lease ROU assets and liabilities, with the exception of short-term leases, are recognized at the commencement date based on the present value of lease payments over the lease term. The Company estimates the discount rate based on the information available at the lease commencement date unless the implicit rate is readily determinable. For leases that commenced prior to the adoption of Topic 842, the Company used the discount rate on February 1, 2022. The lease ROU assets also include any lease payments made and exclude lease incentives such as tenant improvement allowances. Options to extend the lease term are included in the lease term when it is reasonably certain the extension option will be exercised. Upon adoption of ASC 842, the Company recognized operating lease ROU assets and operating lease liabilities of $6.7 million and $7.5 million, respectively, as of February 1, 2022 and did not include any retrospective adjustments to comparative periods to reflect the adoption of ASC 842. The difference of $0.8 million between operating lease ROU assets and operating lease liabilities at the adoption date related to deferred rent. See Note 8, “Leases” to the Notes to Condensed Consolidated Financial Statements for more information. Accounting Pronouncements Not Yet Adopted Under the Jumpstart Our Business Startups Act (the “JOBS Act”), the Company meets the definition of an emerging growth company and can delay adopting new or revised accounting standards issued after the enactment of the JOBS Act until such time as those standards apply to private companies. The Company has elected to use this extended transition period for complying with new or revised accounting standards that have different effective dates for public and private companies until the Company is no longer an emerging growth company or until the Company affirmatively and irrevocably opts out of the extended transition period. In June 2016, the FASB issued ASU 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which requires a financial asset measured at amortized cost basis to be presented at the net amount expected to be collected, with further clarifications made more recently. For trade receivables, loans and other financial instruments, the Company will be required to use a forward-looking expected loss model rather than the incurred loss model for recognizing credit losses which reflects losses that are probable. Credit losses relating to available-for-sale debt securities are required to be recorded through an allowance for credit losses rather than as a reduction in the amortized cost basis of the securities. The Company plans to adopt this standard on February 1, 2023 and is currently evaluating the impact of the adoption on its condensed consolidated financial statements.

Cash Equivalents and Short-Term Investments

6 Months Ended

Jul. 31, 2022

Cash, Cash Equivalents, and Short-Term Investments [Abstract]

Cash Equivalents and Short-Term Investments

The following tables summarize the Company’s cash equivalents and short-term investments (in thousands):


	As of July 31, 2022
	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Estimated Fair Value
Cash Equivalents
Money market funds	$	42,090	$	—	$	—	$	42,090
Total cash equivalents	42,090		—		—		42,090
Short-Term Investments
U.S. government securities	92,755		—		(929)		91,826
Corporate debt securities	27,460		—		(106)		27,354
Commercial paper	23,647		—		—		23,647
Asset-backed securities	2,948		—		(8)		2,940
Total short-term investments	146,810		—		(1,043)		145,767
Total	$	188,900	$	—	$	(1,043)	$	187,857


	As of January 31, 2022
	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Estimated Fair Value
Cash Equivalents
Money market funds	$	86,505	$	—	$	—	$	86,505
Total cash equivalents	86,505		—		—		86,505
Short-Term Investments
U.S. government treasury securities	39,340		—		(129)		39,211
Corporate debt securities	30,156		—		(66)		30,090
Commercial paper	40,966		—		(1)		40,965
Total short-term investments	110,462		—		(196)		110,266
Total	$	196,967	$	—	$	(196)	$	196,771

During the three and six months ended July 31, 2022 and 2021, the Company did not reclassify any amounts to earnings from accumulated other comprehensive income (loss) related to unrealized gains or losses in other income (expense), net in the condensed consolidated statements of operations.

As of July 31, 2022, the Company’s short-term investments consisted of $118.5 million and $27.3 million with a contractual maturity date of less than one year and greater than one year, respectively. As of January 31, 2022, the Company’s short-term investments consisted of $108.3 million and $2.0 million with a contractual maturity of less than one year and greater than one year, respectively.

As of July 31, 2022, the Company had 35 short-term investments in an unrealized loss position. These short-term investments had an estimated fair value of $122.1 million and were not in a continuous unrealized loss position for more than twelve months. As of January 31, 2022, the Company had 25 short-term investments in an unrealized loss position. These short-term investments had an estimated fair value of $71.8 million and were not in a continuous unrealized loss position for more than twelve months. During the three and six months ended July 31, 2022, the Company had no other-than-temporary impairments of short-term investments.

Fair Value Measurements

6 Months Ended

Jul. 31, 2022

Fair Value Disclosures [Abstract]

Fair Value Measurements

The Company accounts for certain of its financial assets and liabilities at fair value. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the reporting date. The accounting guidance establishes a three-tiered hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value as follows:

Level 1: Observable inputs, such as quoted prices in active markets for identical assets or liabilities.

Level 2: Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

Level 3: Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

The carrying amounts reflected on the condensed consolidated balance sheets for cash equivalents, accounts receivable, accounts payable and accrued liabilities approximate fair value due to the short maturities of those instruments.

The following tables present the fair value hierarchy for the Company’s assets measured at fair value on a recurring basis (in thousands):


	As of July 31, 2022
	Level 1		Level 2		Total
Cash Equivalents
Money market funds	$	42,090	$	—	$	42,090
Total cash equivalents	42,090		—		42,090
Short-Term Investments
U.S. government treasury securities	—		91,826		91,826
Corporate debt securities	—		27,354		27,354
Commercial paper	—		23,647		23,647
Asset-backed securities	—		2,940		2,940
Total short-term investments	—		145,767		145,767
Total	$	42,090	$	145,767	$	187,857


	As of January 31, 2022
	Level 1		Level 2		Total
Cash Equivalents
Money market funds	$	86,505	$	—	$	86,505
Total cash equivalents	86,505		—		86,505
Short-Term Investments
U.S. government treasury securities	—		39,211		39,211
Corporate debt securities	—		30,090		30,090
Commercial paper	—		40,965		40,965
Total short-term investments	—		110,266		110,266
Total	$	86,505	$	110,266	$	196,771

The Company classifies its money market funds within Level 1 of the fair value hierarchy because they are valued based on quoted market prices in active markets. The Company classifies its asset-backed securities, commercial paper, U.S. government securities, and corporate debt securities within Level 2 because they are valued using inputs other than quoted prices which are directly or indirectly observable in the market, including readily available pricing sources for the identical underlying security which may not be actively traded.

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

Balance Sheet Components

6 Months Ended

Jul. 31, 2022

Balance Sheet Related Disclosures [Abstract]

Balance Sheet Components

Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consisted of the following (in thousands):


	As of July 31,		As of January 31,
	2022		2022
Prepaid expenses	$	5,765	$	4,518
Prepaid software	2,296		2,297
Other current assets	1,594		1,744
Total prepaid expenses and other current assets	$	9,655	$	8,559

Property and Equipment, Net

Property and equipment, net consisted of the following (in thousands):


	As of July 31,		As of January 31,
	2022		2022
Computer equipment	$	3,426	$	3,711
Furniture and fixtures	415		412
Capitalized internal-use software	7,020		5,772
Leasehold improvements	1,555		1,582
Construction in progress	629		—
Construction in progress—capitalized internal-use software	762		—
Total gross property and equipment	13,807		11,477
Accumulated depreciation and amortization	(8,168)		(7,189)
Total property and equipment, net	$	5,639	$	4,288

Depreciation and amortization expense was $0.8 million and $0.7 million for three months ended July 31, 2022 and 2021, respectively, and $1.5 million and $1.4 million for the six months ended July 31, 2022 and 2021, respectively. Included in these amounts were the amortization of capitalized internal-use software development costs of $0.5 million and $0.5 million in the three months ended July 31, 2022 and 2021, respectively, and $1.0 million and $1.0 million for the six months ended July 31, 2022 and 2021, respectively.

Accrued Compensation and Benefits

Accrued compensation and benefits consisted of the following (in thousands):


	As of July 31,		As of January 31,
	2022		2022
Accrued bonus	$	4,646	$	5,557
Accrued commissions	2,221		4,226
Accrued payroll and benefits	2,352		2,863
Employee contributions under the ESPP	1,311		3,497
Total accrued compensation and benefits	$	10,530	$	16,143

Other Accrued Expenses

Other accrued expenses consisted of the following (in thousands):


	As of July 31,		As of January 31,
	2022		2022
Accrued professional fees	$	779	$	717
Sales and value added tax payable	365		671
Income taxes payable	491		414
Other	2,468		1,429
Total other accrued expenses	$	4,103	$	3,231

Deferred Revenue and Remaining Performance Obligations

6 Months Ended

Jul. 31, 2022

Revenue from Contract with Customer [Abstract]

Deferred Revenue and Remaining Performance Obligations

The following table presents the deferred revenue balances (in thousands):


	As of July 31,		As of January 31,
	2022		2022
Deferred revenue, current	$	67,139	$	69,010
Deferred revenue, noncurrent	2,467		2,713
Total deferred revenue	$	69,606	$	71,723

Changes in the deferred revenue balances during the six months ended July 31, 2022 and 2021 (unaudited) were as follows (in thousands):


	Six Months Ended July 31,
	2022		2021
Beginning balance	$	71,723	$	61,710
Performance obligations satisfied during the period that were included in the deferred revenue balance at the beginning of the year	(43,450)		(38,813)
Increases due to invoicing prior to satisfaction of performance obligations	41,333		31,439
Ending balance	$	69,606	$	54,336

Remaining performance obligations (“RPOs”) represent the amount of contracted future revenue that has not yet been recognized, including both deferred revenue and non-cancelable contracted amounts that will be invoiced and recognized as revenue in future periods.

As of July 31, 2022, the Company’s RPOs were $166.5 million. The Company expects to recognize revenue of $103.1 million of these remaining performance obligations over the next twelve months with the remaining balances recognized thereafter.

- Definition

The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-URI https://asc.fasb.org/topic&trid=49130388

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 10
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (b)(2)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 9
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (e)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 15
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045

+ Details

Debt	6 Months Ended
Debt	Jul. 31, 2022
Debt Disclosure [Abstract]
Debt	Debt Interest expense consisting primarily of unused Credit Facility (as defined below) fees was immaterial for the three and six months ended July 31, 2022. Interest expense on the Company’s borrowings was $0.3 million for the three months ended July 31, 2021, and $0.5 million for the six months ended July 31, 2021. The effective interest rate was 3.9% for the three and six months ended July 31, 2021. Term Loan In August 2018, the Company entered into an agreement for a term loan with a certain lender, which was amended in April 2019 and in June 2020 (the “Amended Loan”). The Amended Loan provided maximum borrowings of up to $25.0 million, maturing in June 2024. In January 2021, the Company repaid all outstanding indebtedness owed pursuant to the Amended Loan and terminated the agreement. Pursuant to the termination of the Amended Loan, the related security interests have been removed and the covenants shall be of no further force and effect. In connection with the April 2019 amendment, the Company issued warrants to purchase 105,350 shares of the Company’s common stock at $7.48 per share, exercisable over 10 years. The fair value of the warrants was recorded to equity and as a debt discount that was amortized to interest over the term of the loan. The total fair value of the common stock warrants was $0.4 million. As of July 31, 2022, all warrants were outstanding and exercisable. Credit Facility In November 2017, the Company entered into a line of credit agreement with Silicon Valley Bank (“Credit Facility”) providing the Company the ability to borrow up to $10.0 million from a revolving line of credit with an original maturity date in November 2018. Borrowings under the line of credit bear interest at a floating per annum rate equal to one half of one percentage point (0.50%) above the prime rate, which interest shall be payable monthly. The line of credit is secured with a pledge on substantially all the assets of the Company, except any intellectual property and is subject to a minimum revenue covenant. In November 2018, the Company entered into an amendment with Silicon Valley Bank to increase the line of credit limit to $15.0 million and extend the maturity date to November 2019. In April 2019, an amendment was entered into with the Silicon Valley Bank to decrease the line of credit to $10.0 million. In April 2020, an amendment was entered into with Silicon Valley Bank to extend the maturity of the line of credit to November 2020. In November 2020, the Company entered into an amendment with Silicon Valley Bank to extend the maturity of the line of credit to February 2021. On January 31, 2021, the Company entered into an amendment with Silicon Valley Bank to increase the line of credit limit to $40.0 million and extend the maturity date to January 2024. Upon the execution of this amendment, the Company borrowed $25.0 million from the line of credit. The outstanding principal balance is due at maturity with interest payable monthly. The line of credit bears a variable annual interest rate of the prime rate plus 0.5%. The Company is required to pay a fee equal to 0.25% per annum on the unused portion of the line of credit. The Company is also subject to a termination fee ranging from 0.5% to 1.0% of the line of credit if the Company terminates the agreement prior to the maturity date. The amendment also added certain financial covenants, including covenants related to certain financial metrics, that if not met, would limit the amount of additional borrowings under the line of credit. The amended line of credit agreement requires the company to maintain an adjusted quick ratio (as defined by the agreement) of at least 1.15 to 1.0. The line of credit agreement also contains certain customary affirmative and negative covenants as well as customary events of default, subject to certain exceptions, including restrictions on the Company’s ability to, among other things, incur debt and liens, maintain collateral accounts, undergo fundamental changes including mergers or consolidations, dispose assets including selling, transferring or assigning assets, pay dividends or other distributions or make or permit payments on any subordinated debt. The Company was in compliance with the financial covenants under the line of credit as of July 31, 2022. The Company repaid the outstanding principal of its revolving line of credit of $25.0 million during the year ended January 31, 2022. There were no borrowings outstanding against the line of credit as of July 31, 2022. As of July 31, 2022, $40.0 million was available for borrowing under the line of credit.

- Definition

The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-URI https://asc.fasb.org/topic&trid=2208564

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (h)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1C
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1I
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1I
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(c))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (g)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1C
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1C
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1E
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1I
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (i)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

+ Details

Leases

6 Months Ended

Jul. 31, 2022

Leases [Abstract]

Leases

The Company leases facilities under non-cancelable operating leases, primarily for rent of office space. Our leases have various expiration dates through November 2027, some of which include options to extend the leases for up to three years. The Company does not have any finance leases.

Operating lease costs were $0.8 million for the three months ended July 31, 2022, and $1.4 million for the six months ended July 31, 2022. Variable lease costs were $0.2 million for the three months ended July 31, 2022 and $0.4 million for the six months ended July 31, 2022. Short-term lease costs were $0.1 million for the three months ended July 31, 2022 and $0.2 million for the six months ended July 31, 2022.

The following table presents supplemental cash flow information related to leases:


	Six months ended July 31, 2022
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash outflows from operating leases	$	1,529
Right-of-use assets obtained in exchange for lease obligations:
Operating leases	$	2,205

The following table presents supplemental balance sheet information related to operating leases (in thousands, except for lease term and discount rate):


	As of July 31, 2022

Operating lease right-of-use assets	$	7,696
Operating lease liabilities	$	3,075
Operating lease liabilities, noncurrent	5,491
Total operating lease liabilities	$	8,566
Weighted-average remaining lease term	3.0 years
Weighted-average discount rate	3.8		%

As of July 31, 2022, remaining maturities of operating lease liabilities were as follows (in thousands):


Period	Operating Leases
Remaining for Fiscal 2023	$	1,654
Fiscal 2024	3,236
Fiscal 2025	2,794
Fiscal 2026	818
Fiscal 2027 and thereafter	571
Total lease payments	9,073
Less: imputed interest	(507)
Total	$	8,566

Future minimum lease payments under non-cancelable operating leases as of January 31, 2022 under ASC 840 were as follows (in thousands):


Year Ending January 31,	Operating Leases
2023	$	2,845
2024	2,638
2025	2,178
2026	362
2027 and thereafter	—
Total	$	8,023

Commitments and Contingencies	6 Months Ended
Commitments and Contingencies	Jul. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Other Contractual Commitments Other contractual commitments relate to third-party cloud infrastructure agreements and subscription arrangements. As of July 31, 2022, there were no material changes to the Company’s contractual commitments since January 31, 2022. Legal Matters From time to time, the Company may be a party to various legal matters, threatened claims, or proceedings in the normal course of business. Legal fees and other costs associated with such actions are expensed as incurred. The Company assesses, in conjunction with its legal counsel, the need to record a liability for litigation and contingencies. Legal accruals are recorded when and if it is determined that a loss related to a certain matter is both probable and reasonably estimable. Indemnification Agreements In the ordinary course of business, the Company enters into agreements of varying scope and terms pursuant to which the Company agrees to indemnify customers, vendors, lessors and other business partners with respect to certain matters, including, but not limited to, losses arising out of the breach of such agreements, services to be provided by the Company or from intellectual property infringement claims made by third parties. Additionally, the Company entered into indemnification agreements with the Company’s directors and officers that require the Company, among other things, to indemnify them against certain liabilities that may arise by reason of their status or service as directors or officers. The Company has not incurred material costs to defend lawsuits or settle claims related to these indemnification agreements nor are we aware of any such claims that could reasonably be expected to incur material costs.

Stockholders' Equity (Deficit) and Employee Incentive Plans

6 Months Ended

Jul. 31, 2022

Equity And Compensation Related Costs Share Based Payments [Abstract]

Stockholders' Equity (Deficit) and Employee Incentive Plans

Stockholders’ Equity (Deficit) and Employee Incentive Plans

Redeemable Convertible Preferred Stock

Upon the closing of the Company’s IPO, all 26,710,600 shares of redeemable convertible preferred stock were automatically converted into shares of common stock, which includes an additional 640,387 shares of redeemable convertible preferred stock. The additional shares of redeemable convertible preferred stock consisted of 162,032 shares for the Series E conversion feature and 478,355 shares for the Series G dividends. The carrying value of $259.8 million was reclassified into common stock and additional paid-in-capital. As of July 31, 2022, there were no shares of redeemable convertible preferred stock issued and outstanding.

In connection with the IPO, the Company’s amended and restated certificate of incorporation became effective, which authorized the issuance of 200,000,000 shares of undesignated preferred stock with a par value of $0.00001 per share with rights and preferences, including voting rights, designated from time to time by the board of directors.

Common Stock

The Company’s Amended and Restated Certificate of Incorporation authorized the Company to issue 1,000,000,000 shares of common stock at a par value of $0.00001 as of July 31, 2022 and January 31, 2022.

Each share of common stock is entitled to one vote. The holders of common stock are also entitled to receive dividends whenever funds are legally available and when and if declared by the board of directors, subject to the prior rights of holders of all classes of stock outstanding. As of July 31, 2022 and January 31, 2022, no dividends had been declared.

As of July 31, 2022, the Company has reserved common stock for future issuance as follows:


			Number of Shares
Stock options outstanding			8,297,260
Restricted stock units issued and outstanding			4,494,972
Remaining shares available for issuance under the 2021 Plan			2,177,442
ESPP			1,030,975
Common stock warrants			105,350
Total			16,105,999

Stock Plans

The Company has three equity incentive plans: the 2008 Equity Incentive Plan (the “2008 Plan”), 2018 Equity Incentive Plan (the “2018 Plan”) and 2021 Equity Incentive Plan (the “2021 Plan”), collectively (the “Stock Plans”). In connection with the Company’s IPO in July 2021, the 2008 Plan and the 2018 Plan were terminated and replaced by the 2021 Plan and all shares that remained available for issuance under the 2018 Plan at that time were reserved for issuance under the 2021 Plan. The number of shares of common stock available for issuance under the 2021 Plan will be increased by any shares of common stock subject to awards outstanding under the 2008 Plan and the 2018 Plan that expire or otherwise terminate without having been exercised or issued in full, are tendered to or withheld by the Company for payment of an exercise price or for satisfying tax withholding obligations or are forfeited to or repurchased by the Company due to failure to vest.

The Company has issued stock options to employees, directors, consultants and advisors pursuant to the 2018 Plan and restricted stock units (“RSUs”) under the 2021 Plan.

Equity awards permitted under the 2021 Plan may be stock options, stock appreciation rights, restricted stock, restricted stock units, performance units and performance shares. Stock option grants may be either Incentive Stock Options (“ISO”) or Non-Qualified Stock Options (“NSO”). ISO may be granted only to Company employees (including officers and directors who are also employees). NSOs may be granted to Company employees, consultants, and nonemployee directors. Employee stock options are granted with an exercise price no less than the fair value of the underlying common stock on the grant date. Options granted under the 2021 Plan expire ten years from the date of grant and generally vest over four years at a rate of 25% upon the first anniversary of the issuance date and 1/48 per month thereafter.

As of July 31, 2022, there were 2.2 million shares available for grant under the 2021 Plan. The 2021 Plan provides that the number of shares reserved will automatically increase on the first day of each fiscal year, beginning on February 1, 2022, by an amount equal to the least of (i) 4,120,000 shares, (ii) five-percent (5%) of the outstanding shares of our common stock on the last day of the immediately preceding fiscal year, or (iii) such number of shares determined by the administrator of the 2021 Plan no later than the last day of the immediately preceding Fiscal Year.

Employee Stock Purchase Plan

In July 2021, the Company established an Employee Stock Purchase Plan (“ESPP”) in which eligible employees may contribute up to 15% of their base compensation to purchase shares of common stock at a price equal to 85% of the lower of (1) the fair market value of a share of the Company’s common stock at the beginning of the offering period and (2) the fair market value of a share of the Company’s common stock on the purchase date. A participant will be permitted to purchase a maximum of shares during each offering period and no participant may purchase more than 1,000 shares during any offering period.

Except for the initial offering period, the ESPP provides for 24-month offering periods beginning March 21 and September 21 of each year, and each offering period will consist of four six-month purchase periods. The initial offering period began on July 22, 2021 and will end on September 20, 2023. The initial offering period consists of four purchase periods with the first purchase date on March 21, 2022, and the final purchase period ending on September 20, 2023.

The Company recognized stock-based compensation expense related to the ESPP of $0.5 million and $1.3 million during the three and six months ended July 31, 2022, respectively. As of July 31, 2022, accrued ESPP employee payroll contributions of $1.3 million are included within accrued compensation and benefits in the consolidated balance sheet. ESPP payroll contributions used to purchase shares are reclassified to stockholders’ equity on the purchase date. As of July 31, 2022, $1.3 million of unrecognized stock-based compensation expense related to the ESPP is expected to be recognized over a weighted-average vesting period of 0.7 years.

During the six months ended July 31, 2022, 237,499 shares of common stock were issued under the ESPP.

Stock Options

The following table summarizes stock option activity under the Stock Plans for the six months ended July 31, 2022 (aggregate intrinsic value in thousands):


	Options Outstanding			Weighted- Average Contractual Term	Aggregate Intrinsic Value
	Number of Options	Weighted- Average Exercise Price
Balances as of January 31, 2022	9,150,821	$	9.76	6.53	$	126,368
Options exercised	(544,257)	$	6.02
Options granted	—	$	—
Options cancelled	(309,304)	$	13.24
Balances as of July 31, 2022	8,297,260	$	9.87	5.95	$	57,061
Options vested and expected to vest as of July 31, 2022	8,297,260	$	9.87	5.95	$	57,061
Options vested and exercisable as of July 31, 2022	6,290,244	$	7.84	5.22	$	50,815

No stock options were granted during the three and six months ended July 31, 2022. Stock options granted during the three months ended July 31, 2021 had a weighted-average grant-date fair value of $11.31 per share. Stock options granted during the six months ended July 31, 2021 had a weighted-average grant-date fair value of $9.30 per share.

The aggregate intrinsic value of options exercised during the three months ended July 31, 2022 and 2021 was $1.0 million and $10.6 million, respectively. The aggregate intrinsic value of options exercised during the six months ended July 31, 2022 and 2021 was $7.7 million and $14.4 million, respectively.

Aggregate intrinsic value represents the difference between the exercise price of the options and the estimated fair value of the Company’s common stock.

The Company recognized stock-based compensation expense related to stock options of $1.7 million and $3.4 million during the three and six months ended July 31, 2022, respectively.

As of July 31, 2022 and January 31, 2022, there was $12.9 million and $17.7 million, respectively, of unrecognized stock-based compensation expense related to unvested stock options, which is expected to be recognized over a weighted-average period of 2.1 years and 2.5 years, for each period.

During the year ended January 31, 2018, in connection with services provided for recruitment, the Company granted 40,646 stock options outside of the Stock Plans to a third party. During the six months ended July 31, 2022, the recipient exercised 16,674 stock options and as of July 31, 2022, the recipient had exercised all 40,646 stock options.

Service-Based RSUs

During the year ended January 31, 2022, the Company began granting RSUs to its employees. RSUs granted had service-based vesting conditions. The service-based vesting condition for these awards is generally satisfied by rendering continuous service for four years, during which time the grants will vest quarterly.

The following table is a summary of service-based RSU activity for the six months ended July 31, 2022:


	RSUs Outstanding
	Number of RSUs	Weighted Average Grant Date Fair Value Per Share
Balances as of January 31, 2022	283,558	$	43.76
RSUs granted	3,451,192	$	18.63
RSUs vested	(125,803)	$	19.87
RSUs forfeited	(271,975)	$	23.04
Balances as of July 31, 2022	3,336,972	$	20.36

The aggregate fair value of the RSU awards granted was $14.6 million and $64.3 million during the three and six months ended July 31, 2022, which represents the fair value of the common stock on the date the service-based vesting awards were granted.

We recognized $4.0 million and $6.4 million in stock-based compensation expense related to service vesting-based RSUs during the three and six months ended July 31, 2022. As of July 31, 2022, there was $62.9 million of unrecognized compensation expense related to service-based RSUs expected to be recognized over a weighted-average vesting period of 3.6 years.

Market-Based RSUs

The following table is a summary of market-based RSU activity for the six months ended July 31, 2022:


	RSUs Outstanding
	Number of RSUs	Weighted Average Grant Date Fair Value Per Share
Balances as of January 31, 2022	1,214,000	$	6.48
RSUs granted	14,000	$	5.30
RSUs vested	—	$	—
RSUs forfeited	(70,000)	$	6.48
Balances as of July 31, 2022	1,158,000	$	6.47

During the year ended January 31, 2022, the Board of Directors granted 1,214,000 restricted stock unit awards with market-based vesting conditions (“market-based RSUs”) to certain executive officers and members of senior

management pursuant to the 2021 Plan. The market-based RSUs are comprised of four tranches that vest depending on a consecutive 60-trading day stock price target of the Company’s common stock. The grant fair value of each tranche was calculated using a Monte Carlo simulation model with the following assumptions:


	Year ended January 31, 2022
Expected term (in years)	5.0
Volatility	50.0	%
Risk-free interest rate	1.7	%
Dividend yield	—

The fair value of the market-based RSUs was estimated at $7.9 million.

During the quarter ended July 31, 2022, the Board of Directors granted 14,000 market-based RSUs to a member of senior management pursuant to the 2021 Plan. The market-based RSUs are comprised of four tranches that vest depending on a consecutive 60-trading day stock price target of the Company’s common stock. The grant fair value of each tranche was calculated using a Monte Carlo simulation model with the following assumptions:


	Three and Six Months Ended July 31, 2022
Expected term (in years)	4.7
Volatility	63.0	%
Risk-free interest rate	2.9	%
Dividend yield	—

The fair value of the market-based RSUs was estimated at $0.1 million.

Stock-based compensation expense related to market-based RSUs was $0.5 million and $1.1 million during the during the three and six months ended July 31, 2022. As of July 31, 2022, there was $6.8 million of unrecognized compensation expense related to market-based RSUs expected to be recognized over an average vesting period of 3.1 years.

Determination of Fair Value

The Company estimates the fair value of stock options and purchase rights issued to employees under the ESPP using the Black-Scholes option-pricing model, which is dependent upon several variables, such as the fair value of the Company’s common stock, the expected option term, expected volatility of the Company’s stock price over the expected term, expected risk-free interest rate over the expected option term, and expected dividend yield.

Expected term—The expected term represents the weighted-average period the stock options are expected to remain outstanding and is calculated using the simplified method, as the Company did not have sufficient historical information to develop reasonable expectations about future exercise patterns and post-vesting employment termination behavior. The simplified method calculates the expected term as the midpoint between the vesting date and the contractual expiration date of the option.

Expected volatility—The expected stock price volatility assumption was determined by examining the historical volatilities for industry peers, as the Company does not have sufficient trading history for the Company’s common stock.

Risk-free interest rate—The risk-free rate assumption is based on the U.S. Treasury instruments whose term was consistent with the expected term of the Company’s awards.

Dividend yield—The expected dividend assumption is based on the Company’s history and expectation of dividend payouts.

Fair value of underlying common stock— Prior to the Company’s IPO, the fair value was determined by the Board of Directors with input from management and contemporaneous independent third-party valuations. Subsequent to the IPO, the fair value of the Company’s common stock is based on the daily average selling price on the Nasdaq Global Select Market.

The fair value of employee stock options was estimated using the following weighted-average assumptions:


	Three Months Ended July 31,			Six Months Ended July 31,
	2022	2021		2022	2021
Stock Option Plans:
Expected term (in years)	*	6.1		*	6.1
Expected volatility	*	42.4	%	*	42.0	%
Risk-free interest rate	*	1.0	%	*	1.0	%
Dividend yield	*	—		*	—

*No stock options were granted during the three and six months ended July 31, 2022.

The fair value of employee stock purchase rights for the offering period under the 2021 ESPP was determined on the date of grant using the Black-Scholes option-pricing model with the following weighted-average assumptions:


			Six Months Ended July 31, 2022
Employee Stock Purchase Plan:
Expected term (in years)			1.1 - 2.1
Expected volatility			46.7% - 52.1%
Risk-free interest rate			0.1% - 0.2%
Dividend yield			—

Stock-Based Compensation

Stock-based compensation expense, net of amounts capitalized was as follows (in thousands):


	Three Months Ended July 31,				Six Months Ended July 31,
	2022		2021		2022		2021
Cost of revenue—subscription	$	141	$	30	$	263	$	57
Cost of revenue—services	117		24		211		46
Research and development	2,087		569		3,986		1,139
Sales and marketing	2,463		688		4,450		1,229
General and administrative	1,919		670		3,267		1,339
Total stock-based compensation expense	$	6,727	$	1,981	$	12,177	$	3,810

Income Taxes	6 Months Ended
Income Taxes	Jul. 31, 2022
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes Accounting for income taxes for interim periods generally requires the provision for income taxes to be determined by applying an estimate of the annual effective tax rate for the full fiscal year to income or loss before income taxes, adjusted for discrete items, if any, for the reporting period. The Company updates its estimate of the annual effective tax rate each quarter and records a cumulative adjustment in such period. The Company recorded income tax expense of $0.4 million and $0.2 million for the three months ended July 31, 2022 and 2021, respectively, and $0.6 million and $0.5 million for the six months ended July 31, 2022 and 2021. Income tax expense consists primarily of income taxes in foreign jurisdictions in which the Company conducts business. Due to the Company’s history of losses in the United States, a full valuation allowance on substantially all of the Company’s deferred tax assets, including net operating loss carryforwards, research and development tax credits, capitalized research and development, and other book versus tax differences was maintained.

- Definition

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 21
-URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 11.C)
-URI https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 17
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 6.I.5.Q1)
-URI https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 14
-URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 270
-Section 50
-Paragraph 1
-URI https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-URI https://asc.fasb.org/topic&trid=2144680

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h)(2))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

+ Details

Geographic Information

6 Months Ended

Jul. 31, 2022

Segment Reporting [Abstract]

Geographic Information

The following table depicts the disaggregation of revenue by geographic area based on the billing address of the customer (in thousands):


	Three Months Ended July 31,				Six Months Ended July 31,
	2022		2021		2022		2021
United States	$	23,806	$	18,336	$	45,142	$	36,383
International	15,985		11,363		29,502		21,271
Total	$	39,791	$	29,699	$	74,644	$	57,654

No individual foreign country contributed 10% or more of total revenue for the three and six months ended July 31, 2022 and 2021.

As of July 31, 2022 and January 31, 2022, the majority of the Company’s long-lived assets, including operating lease ROU assets, were located in the United States.

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 34
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (e)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 26
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 15
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-URI https://asc.fasb.org/topic&trid=2134510

+ Details

Net Loss per Share

6 Months Ended

Jul. 31, 2022

Earnings Per Share [Abstract]

Net Loss per Share

Basic net loss per share attributable to the Company’s common stockholders is computed by dividing the net loss attributable to the Company’s common stockholders by the weighted-average number of shares of common stock outstanding during the period. Diluted net loss per share is the same as basic net loss per share for all years presented because the effects of potentially dilutive items were anti-dilutive given the Company’s net loss position in each period presented.

The following table presents the calculation of basic and diluted net loss per share attributable to common stockholders (in thousands, except per share data):


	Three Months Ended July 31,				Six Months Ended July 31,
	2022		2021		2022		2021
Numerator
Net loss	$	(15,369)	$	(14,470)	$	(35,203)	$	(29,069)
Cumulative dividends on Series G redeemable convertible preferred stock	—		(1,438)		—		(2,917)
Net loss attributable to common stockholders	$	(15,369)	$	(15,908)	$	(35,203)	$	(31,986)
Denominator
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted	44,648		9,045		44,459		7,696
Net loss per share attributable to common stockholders, basic and diluted	$	(0.34)	$	(1.76)	$	(0.79)	$	(4.16)

The following potentially dilutive securities were excluded from the computation of diluted net loss per share for the periods presented because the impact of including them would have been anti-dilutive (in thousands):


	As of July 31,
	2022	2021
Stock options	8,297	9,909
RSUs	4,495	—
Employee stock purchase rights under the ESPP	154	—
Common stock warrants	105	105

Total	13,051	10,014

Basis of Presentation and Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Jul. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Basis of Presentation The Company’s unaudited condensed consolidated financial statements and accompanying notes have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”), regarding interim financial reporting. As permitted under those rules, certain footnotes or other financial information that are normally required by GAAP have been condensed or omitted, and accordingly the balance sheet as of January 31, 2022, and related disclosures, have been derived from the audited consolidated financial statements at that date but do not include all the information required by GAAP for complete consolidated financial statements. These unaudited condensed consolidated financial statements have been prepared on the same basis as the Company’s annual consolidated financial statements and, in the opinion of management, reflect all adjustments (consisting of only normal recurring adjustments) that are necessary for the fair statement of the Company’s condensed consolidated financial information. The results of operations for the three and six months ended July 31, 2022, are not necessarily indicative of the results to be expected for the year ending January 31, 2023, or for any other interim period or for any other future year. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and the related notes contained in the Company’s Annual Report on Form 10-K for the year ended January 31, 2022, as filed with the SEC on March 31, 2022.
Fiscal Year	Fiscal Year The Company’s fiscal year ends on January 31. Unless otherwise stated, references to year in these condensed consolidated financial statements relate to fiscal year rather than calendar year.
Principles of Consolidation	Principles of Consolidation The accompanying condensed consolidated financial statements include the accounts of Couchbase, Inc. and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.
Use of Estimates	Use of Estimates The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts stated in the financial statements and accompanying notes. Such estimates include standalone selling prices for each distinct performance obligation, capitalized internal-use software costs, expected period of benefit for deferred commissions, valuation of the Company’s common stock prior to the IPO in July 2021, valuation of stock-based awards, the determination of allowance for doubtful accounts, the incremental borrowing rate used to measure operating liabilities, and accounting for income taxes. The Company bases its estimates on historical experience and assumptions that management considers reasonable. The Company assesses these estimates on a regular basis; however, actual results could differ from these estimates. Estimates and assumptions about future events and their effects, including the impact of the COVID-19 pandemic, cannot be determined with certainty and therefore require increased judgment. These estimates and assumptions may change in future periods and will be recognized in the condensed consolidated financial statements as new events occur and additional information becomes known. To the extent the Company’s actual results differ materially from those estimates and assumptions, the Company’s future financial statements could be affected. COVID-19 While the duration and extent of the COVID-19 pandemic depends on future developments that cannot be accurately predicted at this time, such as the extent and effectiveness of containment actions, it has already had an adverse effect on the global economy and the lasting effects of the pandemic continue to be unknown. The Company may experience customer losses, including due to bankruptcy or customers ceasing operations, which may result in delays in collections or an inability to collect accounts receivable from these customers. The impact of COVID-19 on the Company’s financial condition, results of operations, or liquidity continues to remain uncertain, and as of the date of issuance of these financial statements, the Company is not aware of any specific event or circumstance that would require an update to its estimates or judgments or an adjustment to the carrying value of the Company’s assets or liabilities. These estimates may change, as new events occur and additional information is obtained, which will be recognized in the condensed consolidated financial statements as soon as they become known. Actual results could differ from those estimates, and any such differences may be material to the Company’s financial statements.
Recent Accounting Pronouncements	Recent Accounting Pronouncements Recently Adopted Accounting Pronouncements In August 2018, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2018-15, Intangibles—Goodwill and Other— Internal-Use Software, which aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal use software license). The accounting for the service element of a hosting arrangement that is a service contract is not affected by the amendments in this ASU. The Company adopted this guidance on February 1, 2022 prospectively for implementation costs incurred after the date of adoption, and the adoption did not have a material impact on its consolidated financial statements. In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which simplifies the accounting for income taxes by amending and clarifying existing guidance in ASC 740, as well as removing certain exceptions within ASC 740. The Company adopted this guidance on February 1, 2022, and the adoption did not have a material impact on its consolidated financial statements. Leases In February 2016, the FASB issued Accounting Standards Update (“ASU”) No. 2016-02 and several amendments, codified as ASC 842, Leases which amends the existing accounting standards for leases. The new standard requires lessees to record a right-of-use (“ROU”) asset and a corresponding lease liability on the balance sheet (with the exception of short-term leases). For lessees, leases will continue to be classified as either operating or financing in the income statement. The Company adopted the guidance on February 1, 2022 utilizing the modified retrospective transition method through a cumulative-effect adjustment at the beginning of the first quarter of fiscal 2023. The Company elected the package of transitional practical expedients upon which, among other provisions, allowed the Company not to reassess under the new standard prior conclusions about lease identification, lease classification and initial direct costs, for any existing leases on the adoption date. The Company elected not to record leases that, at the commencement date, have a lease term of 12 months or less. The Company did not elect to apply the hindsight practical expedient when determining lease term and assessing impairment of ROU assets. The Company also did not elect to combine its lease and non-lease components. Non-lease components that are not fixed are expensed as incurred as variable lease payments. Lease ROU assets and liabilities, with the exception of short-term leases, are recognized at the commencement date based on the present value of lease payments over the lease term. The Company estimates the discount rate based on the information available at the lease commencement date unless the implicit rate is readily determinable. For leases that commenced prior to the adoption of Topic 842, the Company used the discount rate on February 1, 2022. The lease ROU assets also include any lease payments made and exclude lease incentives such as tenant improvement allowances. Options to extend the lease term are included in the lease term when it is reasonably certain the extension option will be exercised. Upon adoption of ASC 842, the Company recognized operating lease ROU assets and operating lease liabilities of $6.7 million and $7.5 million, respectively, as of February 1, 2022 and did not include any retrospective adjustments to comparative periods to reflect the adoption of ASC 842. The difference of $0.8 million between operating lease ROU assets and operating lease liabilities at the adoption date related to deferred rent. See Note 8, “Leases” to the Notes to Condensed Consolidated Financial Statements for more information. Accounting Pronouncements Not Yet Adopted Under the Jumpstart Our Business Startups Act (the “JOBS Act”), the Company meets the definition of an emerging growth company and can delay adopting new or revised accounting standards issued after the enactment of the JOBS Act until such time as those standards apply to private companies. The Company has elected to use this extended transition period for complying with new or revised accounting standards that have different effective dates for public and private companies until the Company is no longer an emerging growth company or until the Company affirmatively and irrevocably opts out of the extended transition period. In June 2016, the FASB issued ASU 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which requires a financial asset measured at amortized cost basis to be presented at the net amount expected to be collected, with further clarifications made more recently. For trade receivables, loans and other financial instruments, the Company will be required to use a forward-looking expected loss model rather than the incurred loss model for recognizing credit losses which reflects losses that are probable. Credit losses relating to available-for-sale debt securities are required to be recorded through an allowance for credit losses rather than as a reduction in the amortized cost basis of the securities. The Company plans to adopt this standard on February 1, 2023 and is currently evaluating the impact of the adoption on its condensed consolidated financial statements.

Cash Equivalents and Short-Term Investments (Tables)

6 Months Ended

Jul. 31, 2022

Cash, Cash Equivalents, and Short-Term Investments [Abstract]

Schedule of Cash Equivalents and Short-term Investments

The following tables summarize the Company’s cash equivalents and short-term investments (in thousands):


	As of July 31, 2022
	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Estimated Fair Value
Cash Equivalents
Money market funds	$	42,090	$	—	$	—	$	42,090
Total cash equivalents	42,090		—		—		42,090
Short-Term Investments
U.S. government securities	92,755		—		(929)		91,826
Corporate debt securities	27,460		—		(106)		27,354
Commercial paper	23,647		—		—		23,647
Asset-backed securities	2,948		—		(8)		2,940
Total short-term investments	146,810		—		(1,043)		145,767
Total	$	188,900	$	—	$	(1,043)	$	187,857


	As of January 31, 2022
	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Estimated Fair Value
Cash Equivalents
Money market funds	$	86,505	$	—	$	—	$	86,505
Total cash equivalents	86,505		—		—		86,505
Short-Term Investments
U.S. government treasury securities	39,340		—		(129)		39,211
Corporate debt securities	30,156		—		(66)		30,090
Commercial paper	40,966		—		(1)		40,965
Total short-term investments	110,462		—		(196)		110,266
Total	$	196,967	$	—	$	(196)	$	196,771

Fair Value Measurements (Tables)

6 Months Ended

Jul. 31, 2022

Fair Value Disclosures [Abstract]

Schedule of Fair Value Hierarchy For Company's Assets Measured at Fair Value on Recurring Basis

The following tables present the fair value hierarchy for the Company’s assets measured at fair value on a recurring basis (in thousands):


	As of July 31, 2022
	Level 1		Level 2		Total
Cash Equivalents
Money market funds	$	42,090	$	—	$	42,090
Total cash equivalents	42,090		—		42,090
Short-Term Investments
U.S. government treasury securities	—		91,826		91,826
Corporate debt securities	—		27,354		27,354
Commercial paper	—		23,647		23,647
Asset-backed securities	—		2,940		2,940
Total short-term investments	—		145,767		145,767
Total	$	42,090	$	145,767	$	187,857


	As of January 31, 2022
	Level 1		Level 2		Total
Cash Equivalents
Money market funds	$	86,505	$	—	$	86,505
Total cash equivalents	86,505		—		86,505
Short-Term Investments
U.S. government treasury securities	—		39,211		39,211
Corporate debt securities	—		30,090		30,090
Commercial paper	—		40,965		40,965
Total short-term investments	—		110,266		110,266
Total	$	86,505	$	110,266	$	196,771

Balance Sheet Components (Tables)

6 Months Ended

Jul. 31, 2022

Balance Sheet Related Disclosures [Abstract]

Schedule of Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consisted of the following (in thousands):


	As of July 31,		As of January 31,
	2022		2022
Prepaid expenses	$	5,765	$	4,518
Prepaid software	2,296		2,297
Other current assets	1,594		1,744
Total prepaid expenses and other current assets	$	9,655	$	8,559

Schedule of Property and Equipment, Net

Property and equipment, net consisted of the following (in thousands):


	As of July 31,		As of January 31,
	2022		2022
Computer equipment	$	3,426	$	3,711
Furniture and fixtures	415		412
Capitalized internal-use software	7,020		5,772
Leasehold improvements	1,555		1,582
Construction in progress	629		—
Construction in progress—capitalized internal-use software	762		—
Total gross property and equipment	13,807		11,477
Accumulated depreciation and amortization	(8,168)		(7,189)
Total property and equipment, net	$	5,639	$	4,288

Schedule of Accrued Compensation and Benefits

Accrued compensation and benefits consisted of the following (in thousands):


	As of July 31,		As of January 31,
	2022		2022
Accrued bonus	$	4,646	$	5,557
Accrued commissions	2,221		4,226
Accrued payroll and benefits	2,352		2,863
Employee contributions under the ESPP	1,311		3,497
Total accrued compensation and benefits	$	10,530	$	16,143

Schedule of Other Accrued Expenses

Other accrued expenses consisted of the following (in thousands):


	As of July 31,		As of January 31,
	2022		2022
Accrued professional fees	$	779	$	717
Sales and value added tax payable	365		671
Income taxes payable	491		414
Other	2,468		1,429
Total other accrued expenses	$	4,103	$	3,231

Deferred Revenue and Remaining Performance Obligations (Tables)

6 Months Ended

Jul. 31, 2022

Revenue from Contract with Customer [Abstract]

Schedule of Deferred Revenue Balances and Changes in Deferred Revenues Balances

The following table presents the deferred revenue balances (in thousands):


	As of July 31,		As of January 31,
	2022		2022
Deferred revenue, current	$	67,139	$	69,010
Deferred revenue, noncurrent	2,467		2,713
Total deferred revenue	$	69,606	$	71,723

Changes in the deferred revenue balances during the six months ended July 31, 2022 and 2021 (unaudited) were as follows (in thousands):


	Six Months Ended July 31,
	2022		2021
Beginning balance	$	71,723	$	61,710
Performance obligations satisfied during the period that were included in the deferred revenue balance at the beginning of the year	(43,450)		(38,813)
Increases due to invoicing prior to satisfaction of performance obligations	41,333		31,439
Ending balance	$	69,606	$	54,336

Leases (Tables)

6 Months Ended

Jul. 31, 2022

Leases [Abstract]

Schedule of Supplemental Cash Flow Related to Leases

The following table presents supplemental cash flow information related to leases:


	Six months ended July 31, 2022
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash outflows from operating leases	$	1,529
Right-of-use assets obtained in exchange for lease obligations:
Operating leases	$	2,205

Schedule of Supplemental Balance Sheet Information

The following table presents supplemental balance sheet information related to operating leases (in thousands, except for lease term and discount rate):


	As of July 31, 2022

Operating lease right-of-use assets	$	7,696
Operating lease liabilities	$	3,075
Operating lease liabilities, noncurrent	5,491
Total operating lease liabilities	$	8,566
Weighted-average remaining lease term	3.0 years
Weighted-average discount rate	3.8		%

Schedule of Operating Lease Maturities

As of July 31, 2022, remaining maturities of operating lease liabilities were as follows (in thousands):


Period	Operating Leases
Remaining for Fiscal 2023	$	1,654
Fiscal 2024	3,236
Fiscal 2025	2,794
Fiscal 2026	818
Fiscal 2027 and thereafter	571
Total lease payments	9,073
Less: imputed interest	(507)
Total	$	8,566

Schedule of Future Minimum Rental Payments for Operating Leases

Future minimum lease payments under non-cancelable operating leases as of January 31, 2022 under ASC 840 were as follows (in thousands):


Year Ending January 31,	Operating Leases
2023	$	2,845
2024	2,638
2025	2,178
2026	362
2027 and thereafter	—
Total	$	8,023

Stockholders' Equity (Deficit) and Employee Incentive Plans (Tables)

6 Months Ended

Jul. 31, 2022

Equity And Compensation Related Costs Share Based Payments [Abstract]

Schedule of Reserved Common Stock for Future Issuance

As of July 31, 2022, the Company has reserved common stock for future issuance as follows:


			Number of Shares
Stock options outstanding			8,297,260
Restricted stock units issued and outstanding			4,494,972
Remaining shares available for issuance under the 2021 Plan			2,177,442
ESPP			1,030,975
Common stock warrants			105,350
Total			16,105,999

Schedule of Stock Option Activity under Stock Plans

The following table summarizes stock option activity under the Stock Plans for the six months ended July 31, 2022 (aggregate intrinsic value in thousands):


	Options Outstanding			Weighted- Average Contractual Term	Aggregate Intrinsic Value
	Number of Options	Weighted- Average Exercise Price
Balances as of January 31, 2022	9,150,821	$	9.76	6.53	$	126,368
Options exercised	(544,257)	$	6.02
Options granted	—	$	—
Options cancelled	(309,304)	$	13.24
Balances as of July 31, 2022	8,297,260	$	9.87	5.95	$	57,061
Options vested and expected to vest as of July 31, 2022	8,297,260	$	9.87	5.95	$	57,061
Options vested and exercisable as of July 31, 2022	6,290,244	$	7.84	5.22	$	50,815

Schedule of Share-based Payment Arrangement, Restricted Stock Unit, Activity

The following table is a summary of service-based RSU activity for the six months ended July 31, 2022:


	RSUs Outstanding
	Number of RSUs	Weighted Average Grant Date Fair Value Per Share
Balances as of January 31, 2022	283,558	$	43.76
RSUs granted	3,451,192	$	18.63
RSUs vested	(125,803)	$	19.87
RSUs forfeited	(271,975)	$	23.04
Balances as of July 31, 2022	3,336,972	$	20.36

The following table is a summary of market-based RSU activity for the six months ended July 31, 2022:


	RSUs Outstanding
	Number of RSUs	Weighted Average Grant Date Fair Value Per Share
Balances as of January 31, 2022	1,214,000	$	6.48
RSUs granted	14,000	$	5.30
RSUs vested	—	$	—
RSUs forfeited	(70,000)	$	6.48
Balances as of July 31, 2022	1,158,000	$	6.47

Schedule of Share-based Payment Award, Restricted Stock Units, Valuation Assumptions

The grant fair value of each tranche was calculated using a Monte Carlo simulation model with the following assumptions:


	Year ended January 31, 2022
Expected term (in years)	5.0
Volatility	50.0	%
Risk-free interest rate	1.7	%
Dividend yield	—

The grant fair value of each tranche was calculated using a Monte Carlo simulation model with the following assumptions:


	Three and Six Months Ended July 31, 2022
Expected term (in years)	4.7
Volatility	63.0	%
Risk-free interest rate	2.9	%
Dividend yield	—

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

The fair value of employee stock options was estimated using the following weighted-average assumptions:


	Three Months Ended July 31,			Six Months Ended July 31,
	2022	2021		2022	2021
Stock Option Plans:
Expected term (in years)	*	6.1		*	6.1
Expected volatility	*	42.4	%	*	42.0	%
Risk-free interest rate	*	1.0	%	*	1.0	%
Dividend yield	*	—		*	—

*No stock options were granted during the three and six months ended July 31, 2022.

Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions


			Six Months Ended July 31, 2022
Employee Stock Purchase Plan:
Expected term (in years)			1.1 - 2.1
Expected volatility			46.7% - 52.1%
Risk-free interest rate			0.1% - 0.2%
Dividend yield			—

Schedule of Stock-Based Compensation Expense

Stock-Based Compensation

Stock-based compensation expense, net of amounts capitalized was as follows (in thousands):


	Three Months Ended July 31,				Six Months Ended July 31,
	2022		2021		2022		2021
Cost of revenue—subscription	$	141	$	30	$	263	$	57
Cost of revenue—services	117		24		211		46
Research and development	2,087		569		3,986		1,139
Sales and marketing	2,463		688		4,450		1,229
General and administrative	1,919		670		3,267		1,339
Total stock-based compensation expense	$	6,727	$	1,981	$	12,177	$	3,810

Geographic Information (Tables)

6 Months Ended

Jul. 31, 2022

Segment Reporting [Abstract]

Schedule of Disaggregation of Revenue by Geographic Area

The following table depicts the disaggregation of revenue by geographic area based on the billing address of the customer (in thousands):


	Three Months Ended July 31,				Six Months Ended July 31,
	2022		2021		2022		2021
United States	$	23,806	$	18,336	$	45,142	$	36,383
International	15,985		11,363		29,502		21,271
Total	$	39,791	$	29,699	$	74,644	$	57,654

Net Loss per Share (Tables)

6 Months Ended

Jul. 31, 2022

Earnings Per Share [Abstract]

Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders

The following table presents the calculation of basic and diluted net loss per share attributable to common stockholders (in thousands, except per share data):


	Three Months Ended July 31,				Six Months Ended July 31,
	2022		2021		2022		2021
Numerator
Net loss	$	(15,369)	$	(14,470)	$	(35,203)	$	(29,069)
Cumulative dividends on Series G redeemable convertible preferred stock	—		(1,438)		—		(2,917)
Net loss attributable to common stockholders	$	(15,369)	$	(15,908)	$	(35,203)	$	(31,986)
Denominator
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted	44,648		9,045		44,459		7,696
Net loss per share attributable to common stockholders, basic and diluted	$	(0.34)	$	(1.76)	$	(0.79)	$	(4.16)

Schedule of Potentially Dilutive Securities Were Excluded From The Computation of Diluted Net Loss Per Share


	As of July 31,
	2022	2021
Stock options	8,297	9,909
RSUs	4,495	—
Employee stock purchase rights under the ESPP	154	—
Common stock warrants	105	105

Total	13,051	10,014

Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Details) $ / shares in Units, $ in Thousands	1 Months Ended		6 Months Ended
	Jul. 31, 2021 USD ($) $ / shares shares	Jun. 30, 2021	Jul. 31, 2022 USD ($) shares	Feb. 01, 2022 USD ($)	Jan. 31, 2022 USD ($)
Sale of Stock
Consideration received on transaction \| $	$ 214,900
Conversion of convertible securities (in shares)	26,710,600
Preferred stock and dividend features converted into common stock (in shares)	640,387
Operating lease right-of-use assets \| $			$ 7,696	$ 6,700	$ 0
Total operating lease liabilities \| $			$ 8,566	7,500
Deferred rent credit \| $				$ 800
Common Stock
Sale of Stock
Reverse stock split of outstanding common stock		2.5
IPO
Sale of Stock
Number of common stock for sale and issuance (in shares)	9,589,999		0
Common stock public offering price per share (in dollar per share) \| $ / shares	$ 24.00
Conversion of convertible securities (in shares)			26,710,600
Underwriters Option to Purchase Additional Shares
Sale of Stock
Number of common stock for sale and issuance (in shares)	1,250,869

Cash Equivalents and Short-Term Investments - Summary of Cash Equivalents and Short-term Investments (Details) - USD ($) $ in Thousands	Jul. 31, 2022	Jan. 31, 2022
Schedule Of Cash Cash Equivalents And Short Term Investments
Cash equivalents, amortized cost	$ 42,090	$ 86,505
Cash equivalents, estimate fair value	42,090	86,505
Short-Term Investments
Amortized Cost	146,810	110,462
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(1,043)	(196)
Estimated Fair Value	145,767	110,266
Amortized Cost	188,900	196,967
Estimated Fair Value	187,857	196,771
U.S. government securities
Short-Term Investments
Amortized Cost	92,755
Gross Unrealized Gains	0
Gross Unrealized Losses	(929)
Estimated Fair Value	91,826
U.S. government treasury securities
Short-Term Investments
Amortized Cost		39,340
Gross Unrealized Gains		0
Gross Unrealized Losses		(129)
Estimated Fair Value		39,211
Corporate debt securities
Short-Term Investments
Amortized Cost	27,460	30,156
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(106)	(66)
Estimated Fair Value	27,354	30,090
Commercial paper
Short-Term Investments
Amortized Cost	23,647	40,966
Gross Unrealized Gains	0	0
Gross Unrealized Losses	0	(1)
Estimated Fair Value	23,647	40,965
Asset-backed securities
Short-Term Investments
Amortized Cost	2,948
Gross Unrealized Gains	0
Gross Unrealized Losses	(8)
Estimated Fair Value	2,940
Money market funds
Schedule Of Cash Cash Equivalents And Short Term Investments
Cash equivalents, amortized cost	42,090	86,505
Cash equivalents, estimate fair value	$ 42,090	$ 86,505

Cash Equivalents and Short Term Investments - Additional Information (Details)	3 Months Ended	6 Months Ended
	Jul. 31, 2022 USD ($) investment	Jul. 31, 2022 USD ($) investment	Jul. 31, 2021 USD ($)	Jan. 31, 2022 USD ($) investment
Cash and Cash Equivalents [Abstract]
Reclassify from accumulated other comprehensive income (loss)		$ 0	$ 0
Contractual maturity in one year	$ 118,500,000	118,500,000		$ 108,300,000
Contractual maturity greater than one year	$ 27,300,000	$ 27,300,000		$ 2,000,000
Number of short-term investments in unrealized loss position \| Investment \| investment	35	35		25
Short-term investments estimated fair value	$ 122,100,000	$ 122,100,000		$ 71,800,000
Impairment of short-term investments	$ 0	$ 0

Fair Value Measurements - Fair Value Hierarchy For Company's Assets Measured at Fair Value on Recurring Basis (Details) - USD ($) $ in Thousands	Jul. 31, 2022	Jan. 31, 2022
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total cash equivalents	$ 42,090	$ 86,505
Total short-term investments	145,767	110,266
U.S. government treasury securities
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total short-term investments		39,211
Corporate debt securities
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total short-term investments	27,354	30,090
Commercial paper
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total short-term investments	23,647	40,965
Asset-backed securities
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total short-term investments	2,940
Money market funds
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total cash equivalents	42,090	86,505
Fair Value, Recurring
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total cash equivalents	42,090	86,505
Total short-term investments	145,767	110,266
Total	187,857	196,771
Fair Value, Recurring \| U.S. government treasury securities
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total short-term investments	91,826	39,211
Fair Value, Recurring \| Corporate debt securities
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total short-term investments	27,354	30,090
Fair Value, Recurring \| Commercial paper
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total short-term investments	23,647	40,965
Fair Value, Recurring \| Asset-backed securities
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total short-term investments	2,940
Fair Value, Recurring \| Level 1
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total cash equivalents	42,090	86,505
Total short-term investments	0	0
Total	42,090	86,505
Fair Value, Recurring \| Level 1 \| U.S. government treasury securities
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total short-term investments	0	0
Fair Value, Recurring \| Level 1 \| Corporate debt securities
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total short-term investments	0	0
Fair Value, Recurring \| Level 1 \| Commercial paper
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total short-term investments	0	0
Fair Value, Recurring \| Level 1 \| Asset-backed securities
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total short-term investments	0
Fair Value, Recurring \| Level 2
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total cash equivalents	0	0
Total short-term investments	145,767	110,266
Total	145,767	110,266
Fair Value, Recurring \| Level 2 \| U.S. government treasury securities
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total short-term investments	91,826	39,211
Fair Value, Recurring \| Level 2 \| Corporate debt securities
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total short-term investments	27,354	30,090
Fair Value, Recurring \| Level 2 \| Commercial paper
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total short-term investments	23,647	40,965
Fair Value, Recurring \| Level 2 \| Asset-backed securities
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total short-term investments	2,940
Fair Value, Recurring \| Money market funds
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total cash equivalents	42,090	86,505
Fair Value, Recurring \| Money market funds \| Level 1
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total cash equivalents	42,090	86,505
Fair Value, Recurring \| Money market funds \| Level 2
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total cash equivalents	$ 0	$ 0

Balance Sheet Components - Schedule of Prepaid Expenses and Other Current Assets (Details) - USD ($) $ in Thousands	Jul. 31, 2022	Jan. 31, 2022
Balance Sheet Related Disclosures [Abstract]
Prepaid expenses	$ 5,765	$ 4,518
Prepaid software	2,296	2,297
Other current assets	1,594	1,744
Total prepaid expenses and other current assets	$ 9,655	$ 8,559

Balance Sheet Components - Schedule of Property and Equipment, Net (Details) - USD ($) $ in Thousands	Jul. 31, 2022	Jan. 31, 2022
Property Plant And Equipment
Total gross property and equipment	$ 13,807	$ 11,477
Accumulated depreciation and amortization	(8,168)	(7,189)
Total property and equipment, net	5,639	4,288
Computer equipment
Property Plant And Equipment
Total gross property and equipment	3,426	3,711
Furniture and fixtures
Property Plant And Equipment
Total gross property and equipment	415	412
Capitalized internal-use software
Property Plant And Equipment
Total gross property and equipment	7,020	5,772
Leasehold improvements
Property Plant And Equipment
Total gross property and equipment	1,555	1,582
Construction in progress
Property Plant And Equipment
Total gross property and equipment	629	0
Construction in progress—capitalized internal-use software
Property Plant And Equipment
Total gross property and equipment	$ 762	$ 0

Balance Sheet Components - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021
Property Plant And Equipment
Depreciation and amortization	$ 800	$ 700	$ 1,466	$ 1,406
Capitalized internal-use software
Property Plant And Equipment
Depreciation and amortization	$ 500	$ 500	$ 1,000	$ 1,000

Balance Sheet Components - Schedule of Accrued Compensation and Benefits (Details) - USD ($) $ in Thousands	Jul. 31, 2022	Jan. 31, 2022
Accrued Compensation and Benefits
Accrued bonus	$ 4,646	$ 5,557
Accrued commissions	2,221	4,226
Accrued payroll and benefits	2,352	2,863
Employee contributions under the ESPP	1,311	3,497
Total accrued compensation and benefits	$ 10,530	$ 16,143

Balance Sheet Components - Schedule of Other Accrued Expenses (Details) - USD ($) $ in Thousands	Jul. 31, 2022	Jan. 31, 2022
Other Accrued Liabilities
Accrued professional fees	$ 779	$ 717
Sales and value added tax payable	365	671
Income taxes payable	491	414
Other	2,468	1,429
Total other accrued expenses	$ 4,103	$ 3,231

Deferred Revenue and Remaining Performance Obligations - Schedule of Deferred Revenue Balances (Details) - USD ($) $ in Thousands	Jul. 31, 2022	Jan. 31, 2022	Jul. 31, 2021	Jan. 31, 2021
Contract with Customer, Liability
Deferred revenue, current	$ 67,139	$ 69,010
Deferred revenue, noncurrent	2,467	2,713
Total deferred revenue	$ 69,606	$ 71,723	$ 54,336	$ 61,710

Deferred Revenue and Remaining Performance Obligations - Schedule of Changes In Deferred Revenue Balances (Details) - USD ($) $ in Thousands	6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021
Change In Contract With Customer, Liability
Beginning balance	$ 71,723	$ 61,710
Performance obligations satisfied during the period that were included in the deferred revenue balance at the beginning of the year	(43,450)	(38,813)
Increases due to invoicing prior to satisfaction of performance obligations	41,333	31,439
Ending balance	$ 69,606	$ 54,336

Deferred Revenue and Remaining Performance Obligations - Additional Information (Details) $ in Millions	Jul. 31, 2022 USD ($)
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Remaining performance obligation	$ 166.5
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2022-08-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Remaining performance obligation	$ 103.1
Revenue expected to be recognized from remaining performance obligations, period (in months)	12 months

Debt - Additional Information (Details) - USD ($)	1 Months Ended		3 Months Ended		6 Months Ended
Debt - Additional Information (Details) - USD ($)	Jan. 31, 2021	Nov. 30, 2017	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021	Jan. 31, 2022	Jun. 30, 2020	Apr. 30, 2019	Nov. 30, 2018
Debt Instrument
Interest expense, debt			$ 0	$ 300,000	$ 0	$ 500,000
Effective interest rate (as a percent)				3.90%		3.90%
Fair value of common stock									$ 400,000
Credit Facility
Debt Instrument
Maximum borrowing capacity	$ 40,000,000	$ 10,000,000							$ 10,000,000	$ 15,000,000
Borrowed line of credit	$ 25,000,000
Fee payable on unused portion of line of credit (as a percent)	0.25%
Line of credit facility adjusted quick ratio	1.15
Repayment of outstanding principal amount							$ 25,000,000
Line of credit outstanding			0		0
Current borrowing capacity			$ 40,000,000		$ 40,000,000
Credit Facility \| Minimum
Debt Instrument
Line of credit facility termination fee (as a percent)	50.00%
Credit Facility \| Maximum
Debt Instrument
Line of credit facility termination fee (as a percent)	100.00%
Credit Facility \| Prime Rate
Debt Instrument
Variable rate (as a percent)	0.50%	0.50%
Amended Loan \| Loans Payable
Debt Instrument
Maximum borrowing capacity								$ 25,000,000
Warrants issued to purchase common stock (in shares)									105,350
Exercise price of warrants or rights (in dollars per share)									$ 7.48
Warrants exercisable period (in years)									10 years

Leases - Narrative (Details) $ in Millions	3 Months Ended	6 Months Ended
Leases - Narrative (Details) $ in Millions	Jul. 31, 2022 USD ($)	Jul. 31, 2022 USD ($)
Lessee, Lease, Description
Operating lease cost	$ 0.8	$ 1.4
Variable lease cost	0.2	0.4
Short-term lease cost	$ 0.1	$ 0.2
Maximum
Lessee, Lease, Description
Lease term (up to) (in years)	3 years	3 years

Leases - Schedule of cash flow information related to operating lease (Details) $ in Thousands	6 Months Ended
	Jul. 31, 2022 USD ($)
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash outflows from operating leases	$ 1,529
Right-of-use assets obtained in exchange for lease obligations:
Operating leases	$ 2,205

Leases - Schedule of balance sheet information related to operating lease (Details) - USD ($) $ in Thousands	Jul. 31, 2022	Feb. 01, 2022	Jan. 31, 2022
Operating Lease, Assets And Liabilities, Lessee [Abstract]
Operating lease right-of-use assets	$ 7,696	$ 6,700	$ 0
Operating lease liabilities	3,075		0
Operating lease liabilities, noncurrent	5,491		$ 0
Total operating lease liabilities	$ 8,566	$ 7,500
Weighted-average remaining lease term (term)	3 years
Weighted-average discount rate (percent)	3.80%

Leases - Maturities of lease liabilities (Details) - USD ($) $ in Thousands	Jul. 31, 2022	Feb. 01, 2022
Operating Leases
Remaining for Fiscal 2023	$ 1,654
Fiscal 2024	3,236
Fiscal 2025	2,794
Fiscal 2026	818
Fiscal 2027 and thereafter	571
Total lease payments	9,073
Less: imputed interest	(507)
Total operating lease liabilities	$ 8,566	$ 7,500

Leases - Future minimum lease payments (Details) $ in Thousands	Jan. 31, 2022 USD ($)
Operating Leases
2023	$ 2,845
2024	2,638
2025	2,178
2026	362
2027 and thereafter	0
Total	$ 8,023

Stockholders' Equity (Deficit) and Employee Incentive Plans - Additional Information (Details) $ / shares in Units, $ in Thousands		1 Months Ended	3 Months Ended			6 Months Ended			12 Months Ended
	Mar. 20, 2022 purchasePeriod	Jul. 31, 2021 participant $ / shares shares	Jul. 31, 2022 USD ($) vote $ / shares shares	Apr. 30, 2022	Jul. 31, 2021 USD ($) participant $ / shares shares	Jul. 31, 2022 USD ($) vote $ / shares shares	Sep. 21, 2021	Jul. 31, 2021 USD ($) participant $ / shares shares	Jan. 31, 2022 USD ($) $ / shares shares	Jan. 31, 2018 shares
Share Based Compensation Arrangement By Share Based Payment Award
Conversion of convertible securities (in shares)		26,710,600
Common stock, shares authorized (in shares)			1,000,000,000			1,000,000,000			1,000,000,000
Common stock, par value (in dollars per share) \| $ / shares			$ 0.00001			$ 0.00001			$ 0.00001
Number of vote \| vote			1			1
Dividend declared (in dollars per share) \| $ / shares						$ 0			$ 0
Number of shares reserved common stock for future issuance (in shares)			16,105,999			16,105,999
Initial offering period duration (in months)							24 months
Initial offering number of purchase periods \| purchasePeriod	4
Total stock-based compensation expense \| $			$ 6,727		$ 1,981	$ 12,177		$ 3,810
Stock-based compensation, net of amounts capitalized \| $						$ 12,177		3,810
Stock options outstanding
Share Based Compensation Arrangement By Share Based Payment Award
Number of shares reserved common stock for future issuance (in shares)			8,297,260			8,297,260
Total stock-based compensation expense \| $			$ 1,700			$ 3,400
Unrecognized stock-based compensation expense related to unvested stock options \| $			$ 12,900			$ 12,900			$ 17,700
Stock-based compensation expected to be recognized weighted-average period (in years)						2 years 1 month 6 days			2 years 6 months
Options granted (in shares)			0			0
Option granted Weighted-average grant-date fair value (in dollars per share) \| $ / shares			$ 11.31			$ 9.30
Aggregate intrinsic value of options exercised \| $			$ 1,000		$ 10,600	$ 7,700		$ 14,400
Issuance of common stock upon exercise of stock options (in shares)						544,257
Stock options outstanding \| Third Party
Share Based Compensation Arrangement By Share Based Payment Award
Options granted (in shares)										40,646
Issuance of common stock upon exercise of stock options (in shares)			16,674			40,646
Service-Based Restricted Stock Units (RSUs)
Share Based Compensation Arrangement By Share Based Payment Award
Total stock-based compensation expense \| $			$ 4,000			$ 6,400
Stock-based compensation expected to be recognized weighted-average period (in years)						3 years 7 months 6 days
Award requisite service period (in years)				4 years
Aggregate fair value of RSU granted \| $			14,600			$ 64,300
Unrecognized stock-based compensation expense related to service vesting-based RSUs \| $			62,900			$ 62,900
Market-Based Restricted Stock Units (RSUs)
Share Based Compensation Arrangement By Share Based Payment Award
Stock-based compensation expected to be recognized weighted-average period (in years)						3 years 1 month 6 days
Aggregate fair value of RSU granted \| $			100						$ 7,900
Unrecognized stock-based compensation expense related to service vesting-based RSUs \| $			6,800			$ 6,800
RSU granted (in shares)									1,214,000
Stock-based compensation, net of amounts capitalized \| $			$ 500			$ 1,100
2021 Plan
Share Based Compensation Arrangement By Share Based Payment Award
Share-based compensation granted expiration period (in years)						10 years
Share-based compensation vesting period (in years)						4 years
Share-based compensation available for grant (in shares)			2,200,000			2,200,000
Number of shares reserved common stock for future issuance (in shares)			4,120,000			4,120,000
Share-based compensation percentage of outstanding stock (as a percent)						5.00%
2021 Plan \| First Anniversary
Share Based Compensation Arrangement By Share Based Payment Award
Share-based compensation vesting rights (as a percent)						25.00%
ESPP
Share Based Compensation Arrangement By Share Based Payment Award
Employee maximum contribution (as a percent)		15.00%
Discount rate on market value of share (as a percent)		85.00%			85.00%			85.00%
Number of participant may purchase more than 1000 shares \| participant		0			0			0
Total stock-based compensation expense \| $			$ 500			$ 1,300
Employee contributions under the ESPP \| $			1,300			1,300
Unrecognized stock-based compensation expense related to unvested stock options \| $			1,300			$ 1,300
Stock-based compensation expected to be recognized weighted-average period (in years)						8 months 12 days
Share purchases related to ESPP (in shares)						237,499
IPO
Share Based Compensation Arrangement By Share Based Payment Award
Conversion of convertible securities (in shares)						26,710,600
Additional redeemable convertible preferred stock converted into shares of common stock (in shares)						640,387
Number of shares outstanding (in shares)						0
Number of common stock for sale and issuance (in shares)		9,589,999				0
Redeemable convertible preferred stock, shares authorized (in shares)		200,000,000			200,000,000			200,000,000
Redeemable convertible preferred stock , par value (in dollars per share) \| $ / shares		$ 0.00001			$ 0.00001			$ 0.00001
IPO \| Series E
Share Based Compensation Arrangement By Share Based Payment Award
Additional redeemable convertible preferred stock converted into shares of common stock (in shares)						162,032
Redeemable convertible preferred stock carrying amount \| $			$ 259,800			$ 259,800
IPO \| Series G
Share Based Compensation Arrangement By Share Based Payment Award
Additional redeemable convertible preferred stock converted into shares of common stock (in shares)						478,355

Stockholders' Equity (Deficit) and Employee Incentive Plans - Summary of Reserved Common Stock for Future Issuance (Details)	Jul. 31, 2022 shares
Class Of Stock
Number of shares reserved common stock for future issuance (in shares)	16,105,999
Stock options outstanding
Class Of Stock
Number of shares reserved common stock for future issuance (in shares)	8,297,260
Restricted stock units issued and outstanding
Class Of Stock
Number of shares reserved common stock for future issuance (in shares)	4,494,972
Remaining shares available for issuance under the 2021 Plan
Class Of Stock
Number of shares reserved common stock for future issuance (in shares)	2,177,442
ESPP
Class Of Stock
Number of shares reserved common stock for future issuance (in shares)	1,030,975
Common stock warrants
Class Of Stock
Number of shares reserved common stock for future issuance (in shares)	105,350

Stockholders' Equity (Deficit) and Employee Incentive Plans - Summary of Stock Option Activity under Stock Plans (Details) - Stock options outstanding - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2022	Apr. 30, 2022	Jul. 31, 2022	Jan. 31, 2022
Options Outstanding, Number of Options
Beginning balance (in shares)		9,150,821	9,150,821
Options exercised (in shares)			(544,257)
Options granted (in shares)	0		0
Options cancelled (in shares)			(309,304)
Ending balance (in shares)	8,297,260		8,297,260
Options vested and expected to vest (in shares)	8,297,260		8,297,260
Options vested and exercisable (in shares)	6,290,244		6,290,244
Options Outstanding, Weighted Average Exercise Price
Beginning balance (in dollars per share)		$ 9.76	$ 9.76
Options exercised (in dollars per share)			6.02
Options granted (in dollars per share)			0
Options cancelled (in dollars per share)			13.24
Ending balance (in dollars per share)	$ 9.87		9.87
Options vested and expected to vest (in dollars per share)	9.87		9.87
Options vested and exercisable (in dollars per share)	$ 7.84		$ 7.84
Stock Options Additional Disclosures
Options outstanding, weighted average remaining contractual term (in years)		6 years 6 months 10 days	5 years 11 months 12 days
Options vested and expected to vest, weighted-average contractual term (in years)			5 years 11 months 12 days
Options vested and exercisable, weighted-average contractual term (in years)			5 years 2 months 19 days
Options outstanding, aggregate intrinsic value	$ 57,061		$ 57,061	$ 126,368
Options vested and expected to vest, aggregate intrinsic value	57,061		57,061
Options vested and exercisable, aggregate intrinsic value	$ 50,815		$ 50,815

Stockholders' Equity (Deficit) and Employee Incentive Plans - Summary of RSU Activity (Details) - $ / shares	3 Months Ended	6 Months Ended
	Jul. 31, 2022	Jul. 31, 2022
Service-Based Restricted Stock Units (RSUs)
RSUs Outstanding, Number of RSUs
Beginning balance (in shares)		283,558
RSUs granted (in shares)		3,451,192
Vesting of restricted stock units		(125,803)
RSUs forfeited (in shares)		(271,975)
Ending balance (in shares)	3,336,972	3,336,972
RSUs Outstanding, Weighted Average Grant Date Fair Value Per Share
Beginning balance (in dollars per share)		$ 43.76
RSUs granted (in dollars per share)		18.63
RSUs vested (in dollars per share)		19.87
RSUs forfeited (in dollars per share)		23.04
Ending balance (in dollars per share)	$ 20.36	$ 20.36
Market-Based Restricted Stock Units (RSUs)
RSUs Outstanding, Number of RSUs
Beginning balance (in shares)		1,214,000
RSUs granted (in shares)	14,000
Vesting of restricted stock units		0
RSUs forfeited (in shares)		(70,000)
Ending balance (in shares)	1,158,000	1,158,000
RSUs Outstanding, Weighted Average Grant Date Fair Value Per Share
Beginning balance (in dollars per share)		$ 6.48
RSUs granted (in dollars per share)		5.30
RSUs vested (in dollars per share)		0
RSUs forfeited (in dollars per share)		6.48
Ending balance (in dollars per share)	$ 6.47	$ 6.47

Stockholders' Equity (Deficit) and Employee Incentive Plans - Summary of Fair Value of Employee Stock Options Estimated using Weighted-average Assumptions (Details) - shares	3 Months Ended		6 Months Ended		12 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021	Jan. 31, 2022
Share Based Compensation Arrangement By Share Based Payment Award
Expected term (in years)				6 years 1 month 6 days
Expected volatility				42.00%
Risk-free interest rate				1.00%
Market-Based Restricted Stock Units (RSUs)
Share Based Compensation Arrangement By Share Based Payment Award
Expected term (in years)	4 years 8 months 12 days		4 years 8 months 12 days		5 years
Expected volatility	63.00%		63.00%		50.00%
Risk-free interest rate	2.90%		2.90%		1.70%
Dividend yield	0.00%		0.00%		0.00%
Stock options outstanding
Share Based Compensation Arrangement By Share Based Payment Award
Expected term (in years)		6 years 1 month 6 days
Expected volatility		42.40%
Risk-free interest rate		1.00%
Dividend yield		0.00%	0.00%
Options granted (in shares)	0		0

Stockholders' Equity (Deficit) and Employee Incentive Plans - Summary of Weighted-Average Assumptions Used In Estimating Fair Value of Employee Stock Purchase Rights (Details)	6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021
Share Based Compensation Arrangement By Share Based Payment Award
Expected term (in years)		6 years 1 month 6 days
2021 ESPP
Share Based Compensation Arrangement By Share Based Payment Award
Expected volatility, minimum (as a percent)	46.70%
Expected volatility, maximum (as a percent)	52.10%
Risk-free interest rate, minimum (as a percent)	0.10%
Risk-free interest rate, maximum (as a percent)	0.20%
Dividend yield	0.00%
Minimum \| 2021 ESPP
Share Based Compensation Arrangement By Share Based Payment Award
Expected term (in years)	1 year 1 month 6 days
Maximum \| 2021 ESPP
Share Based Compensation Arrangement By Share Based Payment Award
Expected term (in years)	2 years 1 month 6 days

Stockholders' Equity (Deficit) and Employee Incentive Plans - Summary of Stock-based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021
Employee Service Share Based Compensation Allocation Of Recognized Period Costs
Recognized stock-based compensation expense	$ 6,727	$ 1,981	$ 12,177	$ 3,810
Research and development
Employee Service Share Based Compensation Allocation Of Recognized Period Costs
Recognized stock-based compensation expense	2,087	569	3,986	1,139
Sales and marketing
Employee Service Share Based Compensation Allocation Of Recognized Period Costs
Recognized stock-based compensation expense	2,463	688	4,450	1,229
General and administrative
Employee Service Share Based Compensation Allocation Of Recognized Period Costs
Recognized stock-based compensation expense	1,919	670	3,267	1,339
Subscription
Employee Service Share Based Compensation Allocation Of Recognized Period Costs
Recognized stock-based compensation expense	141	30	263	57
Cost of Revenue - Services
Employee Service Share Based Compensation Allocation Of Recognized Period Costs
Recognized stock-based compensation expense	$ 117	$ 24	$ 211	$ 46

Income Taxes - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021
Income Tax Disclosure [Abstract]
Income tax expense	$ 372	$ 151	$ 637	$ 480

- Definition

Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.

+ References + Details

Geographic Information - Schedule of Disaggregation of Revenue by Geographic Area (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021
Segment Reporting Information [Line Items]
Total revenue	$ 39,791	$ 29,699	$ 74,644	$ 57,654
United States
Segment Reporting Information [Line Items]
Total revenue	23,806	18,336	45,142	36,383
International
Segment Reporting Information [Line Items]
Total revenue	$ 15,985	$ 11,363	$ 29,502	$ 21,271

- Definition

Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 5
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 924
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 11.L)
-URI https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856

+ Details

Net Loss per Share - Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021
Numerator
Net loss	$ (15,369)	$ (14,470)	$ (35,203)	$ (29,069)
Cumulative dividends on Series G redeemable convertible preferred stock	0	(1,438)	0	(2,917)
Net loss attributable to common stockholders	(15,369)	(15,908)	(35,203)	(31,986)
Net loss attributable to common stockholders	$ (15,369)	$ (15,908)	$ (35,203)	$ (31,986)
Denominator
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares)	44,648	9,045	44,459	7,696
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in shares)	44,648	9,045	44,459	7,696
Net loss per share attributable to common stockholders, basic (in dollars per share)	$ (0.34)	$ (1.76)	$ (0.79)	$ (4.16)
Net loss per share attributable to common stockholders, diluted (in dollars per share)	$ (0.34)	$ (1.76)	$ (0.79)	$ (4.16)

Net Loss per Share - Schedule of Potentially Dilutive Securities Were Excluded From The Computation of Diluted Net Loss Per Share (Details) - shares shares in Thousands	6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021
Antidilutive Securities Excluded From Computation Of Earnings Per Share
Potentially dilutive securities were excluded from computation of diluted net loss per share (in shares)	13,051	10,014
Stock options
Antidilutive Securities Excluded From Computation Of Earnings Per Share
Potentially dilutive securities were excluded from computation of diluted net loss per share (in shares)	8,297	9,909
RSUs
Antidilutive Securities Excluded From Computation Of Earnings Per Share
Potentially dilutive securities were excluded from computation of diluted net loss per share (in shares)	4,495	0
Employee stock purchase rights under the ESPP
Antidilutive Securities Excluded From Computation Of Earnings Per Share
Potentially dilutive securities were excluded from computation of diluted net loss per share (in shares)	154	0
Common stock warrants
Antidilutive Securities Excluded From Computation Of Earnings Per Share
Potentially dilutive securities were excluded from computation of diluted net loss per share (in shares)	105	105